Aggressive breast cancer can become unresponsive to monoclonal antibody treatment, but targeting tumor-resident bacteria may extend its effectiveness.

Nikki Kodama, Vice President and Program Manager of B-21 Production at Northrop Grumman, was among those in attendance. Contents Speaking at the Black Hills Defense & Industry Symposium ...

ABSTRACT: This review provides a comprehensive overview of the phytochemistry, medicinal properties, and biological activities of the Artemisia species. Artemisia species exhibit a wide range of ...

Eucalyptus tereticornis; HPLC; triterpenoids; ursolic acid; ursolic acid lactone Um método simples ... where A is the amount detected, B is the amount of sample without standards and C is the spiked ...